TRAZODONE SECRETS

Avoid concomitant use of tucatinib with CYP3A substrates, where minimum concentration improvements may perhaps result in really serious or life-threatening toxicities. If unavoidable, minimize CYP3A substrate dose As outlined by product labeling.Watch Intently (1)ribociclib will enhance the degree or impact of triazolam by affecting hepatic/intesti